Vaccine only offers limited protection against mild disease caused by the variant that has been discovered in S.A

Health minister, Zweli Mkhize says they have chosen the AstraZeneca vaccine due to promising results and its flexibility. Mkhize was speaking during a virtual media briefing last night. The briefing follows AstraZeneca's announcement that its vaccine only offers limited protection against mild disease caused by the variant that has been discovered in South Africa. South Africa has already bought one-point-five million doses of the vaccine from the Serum Institute in India of which one million doses arrived in South Africa two weeks ago.